But it's not a business, not in its current implementation. Right now it's a implicit government protected monopoly for lots and lots of things. Case in point

But it's not a business, not in its current implementation. Right now it's a implicit government protected monopoly for lots and lots of things. Case in point: EpiPens which are in the news today. When the government makes it hard to develop alternatives but doesn't pay for the monopoly it creates, it's neither a business nor a right. It's a disaster yet that's where we find ourselves today. http://www.nytimes.com/2016/08/24/upshot/the-epipen-a-case-study-in-health-care-system-dysfunction.html?_r=0 http://www.nytimes.com/2016/08/24/upshot/the-epipen-a-case-s...